Search

Your search keyword '"Magliocco, Anthony"' showing total 809 results
Start Over Author "Magliocco, Anthony"
809 results on '"Magliocco, Anthony"'

1. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

Author

Adamson, Kathi, Albain, Kathy S., Asare, Adam L., Asare, Smita M., Balassanian, Ron, Beckwith, Heather, Berry, Scott M., Berry, Donald A., Boughey, Judy C., Buxton, Meredith B., Chen, Yunn-Yi, Chen, Beiyun, Chien, A. Jo, Chui, Stephen Y., Clark, Amy S., Clennell, Julia L., Datnow, Brian, DeMichele, Angela M., Duan, Xiuzhen, Edmiston, Kirsten K., Elias, Anthony D., Ellis, Erin D., Esserman, Laura L., Euhus, David M., Fadare, Oluwole, Fan, Fang, Feldman, Michael D, Forero-Torres, Andres, Haley, Barbara B., Han, Hyo S., Harada, Shuko, Haugen, Patricia, Helsten, Teresa, Hirst, Gillian L., Hylton, Nola M., Isaacs, Claudine, Kemmer, Kathleen, Khan, Qamar J., Khazai, Laila, Klein, Molly E., Krings, Gregor, Lang, Julie E., LeBeau, Lauren G., Leyland-Jones, Brian, Liu, Minetta C., Lo, Shelly, Lu, Janice, Magliocco, Anthony, Matthews, Jeffrey B., Melisko, Michelle E., Mhawech-Fauceglia, Paulette, Moulder, Stacy L., Murthy, Rashmi K., Nanda, Rita, Northfelt, Donald W., Ocal, Idris T., Olopade, Olufunmilayo, Pambuccian, Stefan, Paoloni, Melissa, Park, John W., Parker, Barbara A., Perlmutter, Jane, Peterson, Garry, Pusztai, Lajos, Rendi, Mara, Rugo, Hope S., Sahoo, Sunati, Sams, Sharon, Sanil, Ashish, Sattar, Husain, Schwab, Richard B., Singhrao, Ruby, Steeg, Katherine, Stringer-Reasor, Erica, Symmans, W. Fraser, Tawfik, Ossama, Tripathy, Debasish, Troxell, Megan L., van't Veer, Laura J., Venters, Sara J., Vinh, Tuyethoa, Viscusi, Rebecca K., Wallace, Anne M., Wei, Shi, Wilson, Amy, Yau, Christina, Yee, Douglas, Zeck, Jay C., Osdoit, Marie, van der Noordaa, Marieke, Shad, Sonal, Wei, Jane, de Croze, Diane, Hamy, Anne-Sophie, Laé, Marick, Reyal, Fabien, Sonke, Gabe S, Steenbruggen, Tessa G, van Seijen, Maartje, Wesseling, Jelle, Martín, Miguel, del Monte-Millán, Maria, López-Tarruella, Sara, Boughey, Judy C, Goetz, Matthew P, Hoskin, Tanya, Gould, Rebekah, Valero, Vicente, Edge, Stephen B, Abraham, Jean E, Bartlett, John M S, Caldas, Carlos, Dunn, Janet, Earl, Helena, Hayward, Larry, Hiller, Louise, Provenzano, Elena, Sammut, Stephen-John, Thomas, Jeremy S, Cameron, David, Graham, Ashley, Hall, Peter, Mackintosh, Lorna, Godwin, Andrew K, Schwensen, Kelsey, Sharma, Priyanka, DeMichele, Angela M, Cole, Kimberly, Kim, Mi-Ok, van 't Veer, Laura J, Esserman, Laura J, and Symmans, W Fraser

Published
2022
Full Text
View/download PDF

5. Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704

Author

Lawrence, Yaacov R, Moughan, Jennifer, Magliocco, Anthony M, Klimowicz, Alexander C, Regine, William F, Mowat, Rex B, DiPetrillo, Thomas A, Small, William, Simko, Jeffry P, Golan, Talia, Winter, Kathryn A, Guha, Chandan, Crane, Christopher H, and Dicker, Adam P

Subjects
Rare Diseases, Clinical Research, Pancreatic Cancer, Clinical Trials and Supportive Activities, Digestive Diseases, Cancer, Genetics, Adult, Aged, Aged, 80 and over, Chemoradiotherapy, Adjuvant, DNA Damage, Female, Humans, Male, Middle Aged, MutL Protein Homolog 1, Pancreatic Neoplasms, Proportional Hazards Models, Prospective Studies, biomarkers, chemotherapy, adjuvant, clinical trial phase 3, mutL protein homolog 1, pancreatic neoplasms, radiotherapy, tumor, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis
Abstract

BACKGROUND:The majority of patients with pancreatic cancer who undergo curative resection experience rapid disease recurrence. In previous small studies, high expression of the mismatch-repair protein mutL protein homolog 1 (MLH1) in pancreatic cancers was associated with better outcomes. The objective of this study was to validate the association between MLH1 expression and survival in patients who underwent resection of pancreatic cancer and received adjuvant chemoradiation. METHODS:Samples were obtained from the NRG Oncology Radiation Therapy Oncology Group 9704 prospective, randomized trial (clinicaltrials.gov identifier NCT00003216), which compared 2 adjuvant protocols in patients with pancreatic cancer who underwent resection. Tissue microarrays were prepared from formalin-fixed, paraffin-embedded, resected tumor tissues. MLH1 expression was quantified using fluorescence immunohistochemistry and automated quantitative analysis, and expression was dichotomized above and below the median value. RESULTS:Immunohistochemical staining was successfully performed on 117 patients for MLH1 (60 and 57 patients from the 2 arms). The characteristics of the participants who had tissue samples available were similar to those of the trial population as a whole. At the time of analysis, 84% of participants had died, with a median survival of 17 months. Elevated MLH1 expression levels in tumor nuclei were significantly correlated with longer disease-free and overall survival in each arm individually and in both arms combined. Two-year overall survival was 16% in patients who had low MLH1 expression levels and 53% in those who had high MLH1 expression levels (P

Published
2018

6. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Author

Goode, Ellen L, Block, Matthew S, Kalli, Kimberly R, Vierkant, Robert A, Chen, Wenqian, Fogarty, Zachary C, Gentry-Maharaj, Aleksandra, Tołoczko, Aleksandra, Hein, Alexander, Bouligny, Aliecia L, Jensen, Allan, Osorio, Ana, Hartkopf, Andreas D, Ryan, Andy, Chudecka-Głaz, Anita, Magliocco, Anthony M, Hartmann, Arndt, Jung, Audrey Y, Gao, Bo, Hernandez, Brenda Y, Fridley, Brooke L, McCauley, Bryan M, Kennedy, Catherine J, Wang, Chen, Karpinskyj, Chloe, de Sousa, Christiani B, Tiezzi, Daniel G, Wachter, David L, Herpel, Esther, Taran, Florin Andrei, Modugno, Francesmary, Nelson, Gregg, Lubiński, Jan, Menkiszak, Janusz, Alsop, Jennifer, Lester, Jenny, García-Donas, Jesús, Nation, Jill, Hung, Jillian, Palacios, José, Rothstein, Joseph H, Kelley, Joseph L, de Andrade, Jurandyr M, Robles-Díaz, Luis, Intermaggio, Maria P, Widschwendter, Martin, Beckmann, Matthias W, Ruebner, Matthias, Jimenez-Linan, Mercedes, Singh, Naveena, Oszurek, Oleg, Harnett, Paul R, Rambau, Peter F, Sinn, Peter, Wagner, Philipp, Ghatage, Prafull, Sharma, Raghwa, Edwards, Robert P, Ness, Roberta B, Orsulic, Sandra, Brucker, Sara Y, Johnatty, Sharon E, Longacre, Teri A, Eilber, Ursula, McGuire, Valerie, Sieh, Weiva, Natanzon, Yanina, Li, Zheng, Whittemore, Alice S, deFazio, Anna, Staebler, Annette, Karlan, Beth Y, Gilks, Blake, Bowtell, David D, Høgdall, Estrid, dos Reis, Francisco J Candido, Steed, Helen, Campbell, Ian G, Gronwald, Jacek, Benítez, Javier, Koziak, Jennifer M, Chang-Claude, Jenny, Moysich, Kirsten B, Kelemen, Linda E, Cook, Linda S, Goodman, Marc T, García, María José, Fasching, Peter A, Kommoss, Stefan, Deen, Suha, Kjaer, Susanne K, Menon, Usha, Brenton, James D, Pharoah, Paul DP, Chenevix-Trench, Georgia, Huntsman, David G, Winham, Stacey J, Köbel, Martin, and Ramus, Susan J

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Women's Health, Ovarian Cancer, Cancer, Clinical Research, Rare Diseases, BRCA2 Protein, CD8 Antigens, Carcinoma, Ovarian Epithelial, Cohort Studies, Cystadenocarcinoma, Serous, Female, Humans, Lymphocytes, Tumor-Infiltrating, Middle Aged, Mutation, Neoplasm Grading, Ovarian Neoplasms, Prospective Studies, Survival Analysis, Treatment Outcome, Ovarian Tumor Tissue Analysis (OTTA) Consortium, Public Health and Health Services, Oncology and carcinogenesis
Abstract

ImportanceCytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to other clinical factors.ObjectiveTo define the prognostic role of CD8+ TILs in epithelial ovarian cancer.Design, setting, and participantsThis was a multicenter observational, prospective survival cohort study of the Ovarian Tumor Tissue Analysis Consortium. More than 5500 patients, including 3196 with high-grade serous ovarian carcinomas (HGSOCs), were followed prospectively for over 24 650 person-years.ExposuresFollowing immunohistochemical analysis, CD8+ TILs were identified within the epithelial components of tumor islets. Patients were grouped based on the estimated number of CD8+ TILs per high-powered field: negative (none), low (1-2), moderate (3-19), and high (≥20). CD8+ TILs in a subset of patients were also assessed in a quantitative, uncategorized manner, and the functional form of associations with survival was assessed using penalized B-splines.Main outcomes and measuresOverall survival time.ResultsThe final sample included 5577 women; mean age at diagnosis was 58.4 years (median, 58.2 years). Among the 5 major invasive histotypes, HGSOCs showed the most infiltration. CD8+ TILs in HGSOCs were significantly associated with longer overall survival; median survival was 2.8 years for patients with no CD8+ TILs and 3.0 years, 3.8 years, and 5.1 years for patients with low, moderate, or high levels of CD8+ TILs, respectively (P value for trend = 4.2 × 10−16). A survival benefit was also observed among women with endometrioid and mucinous carcinomas, but not for those with the other histotypes. Among HGSOCs, CD8+ TILs were favorable regardless of extent of residual disease following cytoreduction, known standard treatment, and germline BRCA1 pathogenic mutation, but were not prognostic for BRCA2 mutation carriers. Evaluation of uncategorized CD8+ TIL counts showed a near-log-linear functional form.Conclusions and relevanceThis study demonstrates the histotype-specific nature of immune infiltration and provides definitive evidence for a dose-response relationship between CD8+ TILs and HGSOC survival. That the extent of infiltration is prognostic, not merely its presence or absence, suggests that understanding factors that drive infiltration will be the key to unraveling outcome heterogeneity in this cancer.

Published
2017

7. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Author

Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode, Ellen L, Block, Matthew S, Kalli, Kimberly R, Vierkant, Robert A, Chen, Wenqian, Fogarty, Zachary C, Gentry-Maharaj, Aleksandra, Tołoczko, Aleksandra, Hein, Alexander, Bouligny, Aliecia L, Jensen, Allan, Osorio, Ana, Hartkopf, Andreas, Ryan, Andy, Chudecka-Głaz, Anita, Magliocco, Anthony M, Hartmann, Arndt, Jung, Audrey Y, Gao, Bo, Hernandez, Brenda Y, Fridley, Brooke L, McCauley, Bryan M, Kennedy, Catherine J, Wang, Chen, Karpinskyj, Chloe, de Sousa, Christiani B, Tiezzi, Daniel G, Wachter, David L, Herpel, Esther, Taran, Florin Andrei, Modugno, Francesmary, Nelson, Gregg, Lubiński, Jan, Menkiszak, Janusz, Alsop, Jennifer, Lester, Jenny, García-Donas, Jesús, Nation, Jill, Hung, Jillian, Palacios, José, Rothstein, Joseph H, Kelley, Joseph L, de Andrade, Jurandyr M, Robles-Díaz, Luis, Intermaggio, Maria P, Widschwendter, Martin, Beckmann, Matthias W, Ruebner, Matthias, Jimenez-Linan, Mercedes, Singh, Naveena, Oszurek, Oleg, Harnett, Paul R, Rambau, Peter F, Sinn, Peter, Wagner, Philipp, Ghatage, Prafull, Sharma, Raghwa, Edwards, Robert P, Ness, Roberta B, Orsulic, Sandra, Brucker, Sara Y, Johnatty, Sharon E, Longacre, Teri A, Ursula, Eilber, McGuire, Valerie, Sieh, Weiva, Natanzon, Yanina, Li, Zheng, Whittemore, Alice S, Anna, deFazio, Staebler, Annette, Karlan, Beth Y, Gilks, Blake, Bowtell, David D, Høgdall, Estrid, Candido dos Reis, Francisco J, Steed, Helen, Campbell, Ian G, Gronwald, Jacek, Benítez, Javier, Koziak, Jennifer M, Chang-Claude, Jenny, Moysich, Kirsten B, Kelemen, Linda E, Cook, Linda S, Goodman, Marc T, García, María José, Fasching, Peter A, Kommoss, Stefan, Deen, Suha, Kjaer, Susanne K, Menon, Usha, Brenton, James D, Pharoah, Paul DP, Chenevix-Trench, Georgia, Huntsman, David G, Winham, Stacey J, Köbel, Martin, and Ramus, Susan J

Subjects
Ovarian Tumor Tissue Analysis (OTTA) Consortium, Lymphocytes, Tumor-Infiltrating, Humans, Cystadenocarcinoma, Serous, Ovarian Neoplasms, BRCA2 Protein, Treatment Outcome, Survival Analysis, Cohort Studies, Prospective Studies, Mutation, Middle Aged, Female, Neoplasm Grading, CD8 Antigens, Carcinoma, Ovarian Epithelial, Lymphocytes, Tumor-Infiltrating, Cystadenocarcinoma, Serous, Carcinoma, Ovarian Epithelial, Cancer, Prevention, Ovarian Cancer, Rare Diseases, Vaccine Related, Clinical Research, Oncology and Carcinogenesis, Public Health and Health Services
Abstract

ImportanceCytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to other clinical factors.ObjectiveTo define the prognostic role of CD8+ TILs in epithelial ovarian cancer.Design, setting, and participantsThis was a multicenter observational, prospective survival cohort study of the Ovarian Tumor Tissue Analysis Consortium. More than 5500 patients, including 3196 with high-grade serous ovarian carcinomas (HGSOCs), were followed prospectively for over 24 650 person-years.ExposuresFollowing immunohistochemical analysis, CD8+ TILs were identified within the epithelial components of tumor islets. Patients were grouped based on the estimated number of CD8+ TILs per high-powered field: negative (none), low (1-2), moderate (3-19), and high (≥20). CD8+ TILs in a subset of patients were also assessed in a quantitative, uncategorized manner, and the functional form of associations with survival was assessed using penalized B-splines.Main outcomes and measuresOverall survival time.ResultsThe final sample included 5577 women; mean age at diagnosis was 58.4 years (median, 58.2 years). Among the 5 major invasive histotypes, HGSOCs showed the most infiltration. CD8+ TILs in HGSOCs were significantly associated with longer overall survival; median survival was 2.8 years for patients with no CD8+ TILs and 3.0 years, 3.8 years, and 5.1 years for patients with low, moderate, or high levels of CD8+ TILs, respectively (P value for trend = 4.2 × 10−16). A survival benefit was also observed among women with endometrioid and mucinous carcinomas, but not for those with the other histotypes. Among HGSOCs, CD8+ TILs were favorable regardless of extent of residual disease following cytoreduction, known standard treatment, and germline BRCA1 pathogenic mutation, but were not prognostic for BRCA2 mutation carriers. Evaluation of uncategorized CD8+ TIL counts showed a near-log-linear functional form.Conclusions and relevanceThis study demonstrates the histotype-specific nature of immune infiltration and provides definitive evidence for a dose-response relationship between CD8+ TILs and HGSOC survival. That the extent of infiltration is prognostic, not merely its presence or absence, suggests that understanding factors that drive infiltration will be the key to unraveling outcome heterogeneity in this cancer.

Published
2017

10. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

Author

Machiela, Mitchell J, Zhou, Weiyin, Karlins, Eric, Sampson, Joshua N, Freedman, Neal D, Yang, Qi, Hicks, Belynda, Dagnall, Casey, Hautman, Christopher, Jacobs, Kevin B, Abnet, Christian C, Aldrich, Melinda C, Amos, Christopher, Amundadottir, Laufey T, Arslan, Alan A, Beane-Freeman, Laura E, Berndt, Sonja I, Black, Amanda, Blot, William J, Bock, Cathryn H, Bracci, Paige M, Brinton, Louise A, Bueno-de-Mesquita, H Bas, Burdett, Laurie, Buring, Julie E, Butler, Mary A, Canzian, Federico, Carreon, Tania, Chaffee, Kari G, Chang, I-Shou, Chatterjee, Nilanjan, Chen, Chu, Chen, Constance, Chen, Kexin, Chung, Charles C, Cook, Linda S, Bou, Marta Crous, Cullen, Michael, Davis, Faith G, De Vivo, Immaculata, Ding, Ti, Doherty, Jennifer, Duell, Eric J, Epstein, Caroline G, Fan, Jin-Hu, Figueroa, Jonine D, Fraumeni, Joseph F, Friedenreich, Christine M, Fuchs, Charles S, Gallinger, Steven, Gao, Yu-Tang, Gapstur, Susan M, Garcia-Closas, Montserrat, Gaudet, Mia M, Gaziano, J Michael, Giles, Graham G, Gillanders, Elizabeth M, Giovannucci, Edward L, Goldin, Lynn, Goldstein, Alisa M, Haiman, Christopher A, Hallmans, Goran, Hankinson, Susan E, Harris, Curtis C, Henriksson, Roger, Holly, Elizabeth A, Hong, Yun-Chul, Hoover, Robert N, Hsiung, Chao A, Hu, Nan, Hu, Wei, Hunter, David J, Hutchinson, Amy, Jenab, Mazda, Johansen, Christoffer, Khaw, Kay-Tee, Kim, Hee Nam, Kim, Yeul Hong, Kim, Young Tae, Klein, Alison P, Klein, Robert, Koh, Woon-Puay, Kolonel, Laurence N, Kooperberg, Charles, Kraft, Peter, Krogh, Vittorio, Kurtz, Robert C, LaCroix, Andrea, Lan, Qing, Landi, Maria Teresa, Le Marchand, Loic, Li, Donghui, Liang, Xiaolin, Liao, Linda M, Lin, Dongxin, Liu, Jianjun, Lissowska, Jolanta, Lu, Lingeng, Magliocco, Anthony M, and Malats, Nuria

Published
2016

13. Characterization of Large Structural Genetic Mosaicism in Human Autosomes

Author

Machiela, Mitchell J, Zhou, Weiyin, Sampson, Joshua N, Dean, Michael C, Jacobs, Kevin B, Black, Amanda, Brinton, Louise A, Chang, I-Shou, Chen, Chu, Chen, Constance, Chen, Kexin, Cook, Linda S, Bou, Marta Crous, De Vivo, Immaculata, Doherty, Jennifer, Friedenreich, Christine M, Gaudet, Mia M, Haiman, Christopher A, Hankinson, Susan E, Hartge, Patricia, Henderson, Brian E, Hong, Yun-Chul, Hosgood, H Dean, Hsiung, Chao A, Hu, Wei, Hunter, David J, Jessop, Lea, Kim, Hee Nam, Kim, Yeul Hong, Kim, Young Tae, Klein, Robert, Kraft, Peter, Lan, Qing, Lin, Dongxin, Liu, Jianjun, Le Marchand, Loic, Liang, Xiaolin, Lissowska, Jolanta, Lu, Lingeng, Magliocco, Anthony M, Matsuo, Keitaro, Olson, Sara H, Orlow, Irene, Park, Jae Yong, Pooler, Loreall, Prescott, Jennifer, Rastogi, Radhai, Risch, Harvey A, Schumacher, Fredrick, Seow, Adeline, Setiawan, Veronica Wendy, Shen, Hongbing, Sheng, Xin, Shin, Min-Ho, Shu, Xiao-Ou, Berg, David VanDen, Wang, Jiu-Cun, Wentzensen, Nicolas, Wong, Maria Pik, Wu, Chen, Wu, Tangchun, Wu, Yi-Long, Xia, Lucy, Yang, Hannah P, Yang, Pan-Chyr, Zheng, Wei, Zhou, Baosen, Abnet, Christian C, Albanes, Demetrius, Aldrich, Melinda C, Amos, Christopher, Amundadottir, Laufey T, Berndt, Sonja I, Blot, William J, Bock, Cathryn H, Bracci, Paige M, Burdett, Laurie, Buring, Julie E, Butler, Mary A, Carreón, Tania, Chatterjee, Nilanjan, Chung, Charles C, Cook, Michael B, Cullen, Michael, Davis, Faith G, Ding, Ti, Duell, Eric J, Epstein, Caroline G, Fan, Jin-Hu, Figueroa, Jonine D, Fraumeni, Joseph F, Freedman, Neal D, Fuchs, Charles S, Gao, Yu-Tang, Gapstur, Susan M, Patiño-Garcia, Ana, Garcia-Closas, Montserrat, Gaziano, J Michael, Giles, Graham G, and Gillanders, Elizabeth M

Subjects
Biological Sciences, Genetics, Human Genome, Clinical Research, 2.1 Biological and endogenous factors, Aetiology, Aged, Chromosome Aberrations, Female, Genome, Human, Genome-Wide Association Study, Genotype, Humans, Male, Middle Aged, Mosaicism, Neoplasms, Medical and Health Sciences, Genetics & Heredity, Biological sciences, Biomedical and clinical sciences, Health sciences
Abstract

Analyses of genome-wide association study (GWAS) data have revealed that detectable genetic mosaicism involving large (>2 Mb) structural autosomal alterations occurs in a fraction of individuals. We present results for a set of 24,849 genotyped individuals (total GWAS set II [TGSII]) in whom 341 large autosomal abnormalities were observed in 168 (0.68%) individuals. Merging data from the new TGSII set with data from two prior reports (the Gene-Environment Association Studies and the total GWAS set I) generated a large dataset of 127,179 individuals; we then conducted a meta-analysis to investigate the patterns of detectable autosomal mosaicism (n = 1,315 events in 925 [0.73%] individuals). Restricting to events >2 Mb in size, we observed an increase in event frequency as event size decreased. The combined results underscore that the rate of detectable mosaicism increases with age (p value = 5.5 × 10(-31)) and is higher in men (p value = 0.002) but lower in participants of African ancestry (p value = 0.003). In a subset of 47 individuals from whom serial samples were collected up to 6 years apart, complex changes were noted over time and showed an overall increase in the proportion of mosaic cells as age increased. Our large combined sample allowed for a unique ability to characterize detectable genetic mosaicism involving large structural events and strengthens the emerging evidence of non-random erosion of the genome in the aging population.

Published
2015

14. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

Author

Earp, Madalene A, Kelemen, Linda E, Magliocco, Anthony M, Swenerton, Kenneth D, Chenevix-Trench, Georgia, Australian Cancer Study, Australian Ovarian Cancer Study Group, Lu, Yi, Hein, Alexander, Ekici, Arif B, Beckmann, Matthias W, Fasching, Peter A, Lambrechts, Diether, Despierre, Evelyn, Vergote, Ignace, Lambrechts, Sandrina, Doherty, Jennifer A, Rossing, Mary Anne, Chang-Claude, Jenny, Rudolph, Anja, Friel, Grace, Moysich, Kirsten B, Odunsi, Kunle, Sucheston-Campbell, Lara, Lurie, Galina, Goodman, Marc T, Carney, Michael E, Thompson, Pamela J, Runnebaum, Ingo B, Dürst, Matthias, Hillemanns, Peter, Dörk, Thilo, Antonenkova, Natalia, Bogdanova, Natalia, Leminen, Arto, Nevanlinna, Heli, Pelttari, Liisa M, Butzow, Ralf, Bunker, Clareann H, Modugno, Francesmary, Edwards, Robert P, Ness, Roberta B, du Bois, Andreas, Heitz, Florian, Schwaab, Ira, Harter, Philipp, Karlan, Beth Y, Walsh, Christine, Lester, Jenny, Jensen, Allan, Kjær, Susanne K, Høgdall, Claus K, Høgdall, Estrid, Lundvall, Lene, Sellers, Thomas A, Fridley, Brooke L, Goode, Ellen L, Cunningham, Julie M, Vierkant, Robert A, Giles, Graham G, Baglietto, Laura, Severi, Gianluca, Southey, Melissa C, Liang, Dong, Wu, Xifeng, Lu, Karen, Hildebrandt, Michelle AT, Levine, Douglas A, Bisogna, Maria, Schildkraut, Joellen M, Iversen, Edwin S, Weber, Rachel Palmieri, Berchuck, Andrew, Cramer, Daniel W, Terry, Kathryn L, Poole, Elizabeth M, Tworoger, Shelley S, Bandera, Elisa V, Chandran, Urmila, Orlow, Irene, Olson, Sara H, Wik, Elisabeth, Salvesen, Helga B, Bjorge, Line, Halle, Mari K, van Altena, Anne M, Aben, Katja KH, Kiemeney, Lambertus A, Massuger, Leon FAG, Pejovic, Tanja, Bean, Yukie T, Cybulski, Cezary, Gronwald, Jacek, Lubinski, Jan, Wentzensen, Nicolas, Brinton, Louise A, Lissowska, Jolanta, Garcia-Closas, Montserrat, Dicks, Ed, and Dennis, Joe

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Genetics, Prevention, Cancer Genomics, Rare Diseases, Human Genome, Ovarian Cancer, Women's Health, Cancer, 2.1 Biological and endogenous factors, Alleles, Carcinoma, Ovarian Epithelial, DNA, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Quality Control, Australian Cancer Study, Australian Ovarian Cancer Study Group, Ovarian Cancer Association Consortium, Complementary and Alternative Medicine, Paediatrics and Reproductive Medicine, Genetics & Heredity, Reproductive medicine
Abstract

Epithelial ovarian cancer (EOC) is a heterogeneous cancer with both genetic and environmental risk factors. Variants influencing the risk of developing the less-common EOC subtypes have not been fully investigated. We performed a genome-wide association study (GWAS) of EOC according to subtype by pooling genomic DNA from 545 cases and 398 controls of European descent, and testing for allelic associations. We evaluated for replication 188 variants from the GWAS [56 variants for mucinous, 55 for endometrioid and clear cell, 53 for low-malignant potential (LMP) serous, and 24 for invasive serous EOC], selected using pre-defined criteria. Genotypes from 13,188 cases and 23,164 controls of European descent were used to perform unconditional logistic regression under the log-additive genetic model; odds ratios (OR) and 95 % confidence intervals are reported. Nine variants tagging six loci were associated with subtype-specific EOC risk at P

Published
2014

15. An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms

Author

SALLER, JAMES, WHITE, DALEY, HOUGH, BROOKE, YODER, SEAN, WHITING, JUNMIN, CHEN, DUNG-TSA, MAGLIOCCO, ANTHONY, and COPPOLA, DOMENICO

Subjects
Cancer Research, Genetics, Molecular Biology, Biochemistry, Research Article
Abstract

Background/Aim: Grading pancreatic neuroendocrine neoplasms (PNENs) via mitotic rate and Ki-67 index score is complicated by interobserver variability. Differentially expressed miRNAs (DEMs) are useful for predicting tumour progression and may be useful for grading. Patients and Methods: Twelve PNENs were selected. Four patients had grade (G) 1 pancreatic neuroendocrine tumours (PNETs); 4 had G2 PNETs; and 4 had G3 PNENs (2 PNETs and 2 pancreatic neuroendocrine carcinomas). Samples were profiled using the miRNA NanoString Assay. Results: There were 6 statistically significant DEMs between different grades of PNENs. MiR1285-5p was the sole miRNA differentially expressed (p=0.03) between G1 and G2 PNETs. Six statistically significant DEMs (miR135a-5p, miR200a-3p, miR3151-5p, miR-345-5p, miR548d-5p and miR9-5p) (p

Published
2023
Full Text
View/download PDF

16. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

Author

Abeshouse, Adam, Adebamowo, Clement, Adebamowo, Sally N., Akbani, Rehan, Akeredolu, Teniola, Ally, Adrian, Anderson, Matthew L., Anur, Pavana, Appelbaum, Elizabeth L., Armenia, Joshua, Auman, J. Todd, Bailey, Matthew H., Baker, Laurence, Balasundaram, Miruna, Balu, Saianand, Barthel, Floris P., Bartlett, John, Baylin, Stephen B., Behera, Madhusmita, Belyaev, Dmitry, Bennett, Joesph, Benz, Christopher, Beroukhim, Rameen, Birrer, Michael, Bocklage, Thèrése, Bodenheimer, Tom, Boice, Lori, Bootwalla, Moiz S., Bowen, Jay, Bowlby, Reanne, Boyd, Jeff, Brohl, Andrew S., Brooks, Denise, Byers, Lauren, Carlsen, Rebecca, Castro, Patricia, Chen, Hsiao-Wei, Cherniack, Andrew D., Chibon, Fréderic, Chin, Lynda, Cho, Juok, Chuah, Eric, Chudamani, Sudha, Cibulskis, Carrie, Cooper, Lee A.D., Cope, Leslie, Cordes, Matthew G., Crain, Daniel, Curley, Erin, Danilova, Ludmila, Dao, Fanny, Davis, Ian J., Davis, Lara E., Defreitas, Timothy, Delman, Keith, Demchok, John A., Demetri, George D., Demicco, Elizabeth G., Dhalla, Noreen, Diao, Lixia, Ding, Li, DiSaia, Phil, Dottino, Peter, Doyle, Leona A., Drill, Esther, Dubina, Michael, Eschbacher, Jennifer, Fedosenko, Konstantin, Felau, Ina, Ferguson, Martin L., Frazer, Scott, Fronick, Catrina C., Fulidou, Victoria, Fulton, Lucinda A., Fulton, Robert S., Gabriel, Stacey B., Gao, Jianjiong, Gao, Qingsong, Gardner, Johanna, Gastier-Foster, Julie M., Gay, Carl M., Gehlenborg, Nils, Gerken, Mark, Getz, Gad, Godwin, Andrew K., Godwin, Eryn M., Gordienko, Elena, Grilley-Olson, Juneko E., Gutman, David A., Gutmann, David H., Hayes, D. Neil, Hegde, Apurva M., Heiman, David I., Heins, Zachary, Helsel, Carmen, Hepperla, Austin J., Higgins, Kelly, Hoadley, Katherine A., Hobensack, Shital, Holt, Robert A., Hoon, Dave B., Hornick, Jason L., Hoyle, Alan P., Hu, Xin, Huang, Mei, Hutter, Carolyn M., Iacocca, Mary, Ingram, Davis R., Ittmann, Michael, Iype, Lisa, Jefferys, Stuart R., Jones, Kevin B., Jones, Corbin D., Jones, Steven J.M., Kalir, Tamara, Karlan, Beth Y., Karseladze, Apollon, Kasaian, Katayoon, Kim, Jaegil, Kundra, Ritika, Kuo, Hanluen, Ladanyi, Marc, Lai, Phillip H., Laird, Peter W., Larsson, Erik, Lawrence, Michael S., Lazar, Alexander J., Lee, Sanghoon, Lee, Darlene, Lehmann, Kjong-Van, Leraas, Kristen M., Lester, Jenny, Levine, Douglas A., Li, Irene, Lichtenberg, Tara M., Lin, Pei, Liu, Jia, Liu, Wenbin, Liu, Eric Minwei, Lolla, Laxmi, Lu, Yiling, Ma, Yussanne, Madan, Rashna, Maglinte, Dennis T., Magliocco, Anthony, Maki, Robert G., Mallery, David, Manikhas, Georgy, Mardis, Elaine R., Mariamidze, Armaz, Marra, Marco A., Martignetti, John A., Martinez, Cathleen, Mayo, Michael, McLellan, Michael D., Meier, Sam, Meng, Shaowu, Meyerson, Matthew, Mieczkowski, Piotr A., Miller, Christopher A., Mills, Gordon B., Moore, Richard A., Morris, Scott, Mose, Lisle E., Mozgovoy, Evgeny, Mungall, Andrew J., Mungall, Karen, Nalisnik, Michael, Naresh, Rashi, Newton, Yulia, Noble, Michael S., Novak, Janet E., Ochoa, Angelica, Olvera, Narciso, Owonikoko, Taofeek K., Paklina, Oxana, Parfitt, Jeremy, Parker, Joel S., Pastore, Alessandro, Paulauskis, Joseph, Penny, Robert, Pereira, Elena, Perou, Charles M., Perou, Amy H., Pihl, Todd, Pollock, Raphael E., Potapova, Olga, Radenbaugh, Amie J., Ramalingam, Suresh S., Ramirez, Nilsa C., Rathmell, W. Kimryn, Raut, Chandrajit P., Riedel, Richard F., Reilly, Colleen, Reynolds, Sheila M., Roach, Jeffrey, Robertson, A. Gordon, Roszik, Jason, Rubin, Brian P., Sadeghi, Sara, Saksena, Gordon, Salner, Andrew, Sanchez-Vega, Francisco, Sander, Chris, Schein, Jacqueline E., Schmidt, Heather K., Schultz, Nikolaus, Schumacher, Steven E., Sekhon, Harman, Senbabaoglu, Yasin, Setdikova, Galiya, Shelton, Candace, Shelton, Troy, Shen, Ronglai, Shi, Yan, Shih, Juliann, Shmulevich, Ilya, Sica, Gabriel L., Simons, Janae V., Singer, Samuel, Sipahimalani, Payal, Skelly, Tara, Socci, Nicholas, Sofia, Heidi J., Soloway, Matthew G., Spellman, Paul, Sun, Qiang, Swanson, Patricia, Tam, Angela, Tan, Donghui, Tarnuzzer, Roy, Thiessen, Nina, Thompson, Eric, Thorne, Leigh B., Tong, Pan, Torres, Keila E., van de Rijn, Matt, Van Den Berg, David J., Van Tine, Brian A., Veluvolu, Umadevi, Verhaak, Roel, Voet, Doug, Voronina, Olga, Wan, Yunhu, Wang, Zhining, Wang, Jing, Weinstein, John N., Weisenberger, Daniel J., Wilkerson, Matthew D., Wilson, Richard K., Wise, Lisa, Wong, Tina, Wong, Winghing, Wrangle, John, Wu, Ye, Wyczalkowski, Matthew, Yang, Liming, Yau, Christina, Yellapantula, Venkata, Zenklusen, Jean C., Zhang, Jiashan (Julia), Zhang, Hailei, Zhang, Hongxin, and Zmuda, Erik

Published
2017
Full Text
View/download PDF

25. Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation

Author

Davies, Kurtis D., Farooqi, Midhat S., Gruidl, Mike, Hill, Charles E., Woolworth-Hirschhorn, Julie, Jones, Heather, Jones, Kenneth L., Magliocco, Anthony, Mitui, Midori, O'Neill, Philip H., O'Rourke, Rebecca, Patel, Nirali M., Qin, Dahui, Ramos, Erica, Rossi, Michael R., Schneider, Thomas M., Smith, Geoffrey H., Zhang, Linsheng, Park, Jason Y., and Aisner, Dara L.

Published
2016
Full Text
View/download PDF

27. Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance

Author

Boac, Bernadette M., Xiong, Yin, Marchion, Douglas C., Abbasi, Forough, Bush, Stephen H., Ramirez, Ingrid J., Khulpateea, Beman R., Clair McClung, E., Berry, Amy L., Zgheib, Nadim Bou, Chon, Hye Sook, Shahzad, Mian M., Judson, Patricia L., Wenham, Robert M., Apte, Sachin M., Berglund, Anders E., Magliocco, Anthony M., and Lancaster, Johnathan M.

Published
2016
Full Text
View/download PDF

29. Expression of the BAD pathway is a marker of triple-negative status and poor outcome

Author

Boac, Bernadette M., Abbasi, Forough, Ismail-Khan, Roohi, Xiong, Yin, Siddique, Atif, Park, Hannah, Han, Mingda, Saeed-Vafa, Daryoush, Soliman, Hatem, Henry, Brendon, Pena, M. Juliana, McClung, E. Clair, Robertson, Sharon E., Todd, Sarah L., Lopez, Alex, Sun, Weihong, Apuri, Susmitha, Lancaster, Johnathan M., Berglund, Anders E., Magliocco, Anthony M., and Marchion, Douglas C.

Published
2019
Full Text
View/download PDF

30. Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

Author

Cao, Yu, Trillo-Tinoco, Jimena, Sierra, Rosa A., Anadon, Carmen, Dai, Wenjie, Mohamed, Eslam, Cen, Ling, Costich, Tara L., Magliocco, Anthony, Marchion, Douglas, Klar, Richard, Michel, Sven, Jaschinski, Frank, Reich, Richard R., Mehrotra, Shikhar, Cubillos-Ruiz, Juan R., Munn, David H., Conejo-Garcia, Jose R., and Rodriguez, Paulo C.

Published
2019
Full Text
View/download PDF

31. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

Author

Cao, Yu, Trillo-Tinoco, Jimena, Sierra, Rosa A., Anadon, Carmen, Dai, Wenjie, Mohamed, Eslam, Cen, Ling, Costich, Tara L., Magliocco, Anthony, Marchion, Douglas, Klar, Richard, Michel, Sven, Jaschinski, Frank, Reich, Richard R., Mehrotra, Shikhar, Cubillos-Ruiz, Juan R., Munn, David H., Conejo-Garcia, Jose R., and Rodriguez, Paulo C.

Published
2019
Full Text
View/download PDF

33. Data from Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

Author

Nerlakanti, Niveditha, primary, Yao, Jiqiang, primary, Nguyen, Duy T., primary, Patel, Ami K., primary, Eroshkin, Alexey M., primary, Lawrence, Harshani R., primary, Ayaz, Muhammad, primary, Kuenzi, Brent M., primary, Agarwal, Neha, primary, Chen, Yunyun, primary, Gunawan, Steven, primary, Karim, Rezaul M., primary, Berndt, Norbert, primary, Puskas, John, primary, Magliocco, Anthony M., primary, Coppola, Domenico, primary, Dhillon, Jasreman, primary, Zhang, Jingsong, primary, Shymalagovindarajan, Subramaniam, primary, Rix, Uwe, primary, Kim, Youngchul, primary, Perera, Ranjan, primary, Lawrence, Nicholas J., primary, Schonbrunn, Ernst, primary, and Mahajan, Kiran, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table S1 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

Author

Permuth-Wey, Jennifer, primary, Chen, Dung-Tsa, primary, Fulp, William J., primary, Yoder, Sean J., primary, Zhang, Yonghong, primary, Georgeades, Christina, primary, Husain, Kazim, primary, Centeno, Barbara Ann, primary, Magliocco, Anthony M., primary, Coppola, Domenico, primary, and Malafa, Mokenge, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figures S1-S7 and Supplementary Methods from Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

Author

Nerlakanti, Niveditha, primary, Yao, Jiqiang, primary, Nguyen, Duy T., primary, Patel, Ami K., primary, Eroshkin, Alexey M., primary, Lawrence, Harshani R., primary, Ayaz, Muhammad, primary, Kuenzi, Brent M., primary, Agarwal, Neha, primary, Chen, Yunyun, primary, Gunawan, Steven, primary, Karim, Rezaul M., primary, Berndt, Norbert, primary, Puskas, John, primary, Magliocco, Anthony M., primary, Coppola, Domenico, primary, Dhillon, Jasreman, primary, Zhang, Jingsong, primary, Shymalagovindarajan, Subramaniam, primary, Rix, Uwe, primary, Kim, Youngchul, primary, Perera, Ranjan, primary, Lawrence, Nicholas J., primary, Schonbrunn, Ernst, primary, and Mahajan, Kiran, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Tables S1 to S10 from Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

Author

Nerlakanti, Niveditha, primary, Yao, Jiqiang, primary, Nguyen, Duy T., primary, Patel, Ami K., primary, Eroshkin, Alexey M., primary, Lawrence, Harshani R., primary, Ayaz, Muhammad, primary, Kuenzi, Brent M., primary, Agarwal, Neha, primary, Chen, Yunyun, primary, Gunawan, Steven, primary, Karim, Rezaul M., primary, Berndt, Norbert, primary, Puskas, John, primary, Magliocco, Anthony M., primary, Coppola, Domenico, primary, Dhillon, Jasreman, primary, Zhang, Jingsong, primary, Shymalagovindarajan, Subramaniam, primary, Rix, Uwe, primary, Kim, Youngchul, primary, Perera, Ranjan, primary, Lawrence, Nicholas J., primary, Schonbrunn, Ernst, primary, and Mahajan, Kiran, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure S3 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

Author

Permuth-Wey, Jennifer, primary, Chen, Dung-Tsa, primary, Fulp, William J., primary, Yoder, Sean J., primary, Zhang, Yonghong, primary, Georgeades, Christina, primary, Husain, Kazim, primary, Centeno, Barbara Ann, primary, Magliocco, Anthony M., primary, Coppola, Domenico, primary, and Malafa, Mokenge, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure Legends from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

Author

Permuth-Wey, Jennifer, primary, Chen, Dung-Tsa, primary, Fulp, William J., primary, Yoder, Sean J., primary, Zhang, Yonghong, primary, Georgeades, Christina, primary, Husain, Kazim, primary, Centeno, Barbara Ann, primary, Magliocco, Anthony M., primary, Coppola, Domenico, primary, and Malafa, Mokenge, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Material (Table S1-S3, Figure S1-S2) from High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium

Author

Peres, Lauren C., primary, Mallen, Adrianne R., primary, Townsend, Mary K., primary, Poole, Elizabeth M., primary, Trabert, Britton, primary, Allen, Naomi E., primary, Arslan, Alan A., primary, Dossus, Laure, primary, Fortner, Renée T., primary, Gram, Inger T., primary, Hartge, Patricia, primary, Idahl, Annika, primary, Kaaks, Rudolf, primary, Kvaskoff, Marina, primary, Magliocco, Anthony M., primary, Merritt, Melissa A., primary, Quirós, J. Ramón, primary, Tjonneland, Anne, primary, Trichopoulou, Antonia, primary, Tumino, Rosario, primary, van Gils, Carla H., primary, Visvanathan, Kala, primary, Wentzensen, Nicolas, primary, Zeleniuch-Jacquotte, Anne, primary, and Tworoger, Shelley S., primary

Published
2023
Full Text
View/download PDF

41. Data from High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium

Author

Peres, Lauren C., primary, Mallen, Adrianne R., primary, Townsend, Mary K., primary, Poole, Elizabeth M., primary, Trabert, Britton, primary, Allen, Naomi E., primary, Arslan, Alan A., primary, Dossus, Laure, primary, Fortner, Renée T., primary, Gram, Inger T., primary, Hartge, Patricia, primary, Idahl, Annika, primary, Kaaks, Rudolf, primary, Kvaskoff, Marina, primary, Magliocco, Anthony M., primary, Merritt, Melissa A., primary, Quirós, J. Ramón, primary, Tjonneland, Anne, primary, Trichopoulou, Antonia, primary, Tumino, Rosario, primary, van Gils, Carla H., primary, Visvanathan, Kala, primary, Wentzensen, Nicolas, primary, Zeleniuch-Jacquotte, Anne, primary, and Tworoger, Shelley S., primary

Published
2023
Full Text
View/download PDF

42. Supplemental Tables S1-S5 from The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers

Author

Légaré, Stéphanie, primary, Cavallone, Luca, primary, Mamo, Aline, primary, Chabot, Catherine, primary, Sirois, Isabelle, primary, Magliocco, Anthony, primary, Klimowicz, Alexander, primary, Tonin, Patricia N., primary, Buchanan, Marguerite, primary, Keilty, Dana, primary, Hassan, Saima, primary, Laperrière, David, primary, Mader, Sylvie, primary, Aleynikova, Olga, primary, and Basik, Mark, primary

Published
2023
Full Text
View/download PDF

43. Data from The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers

Author

Légaré, Stéphanie, primary, Cavallone, Luca, primary, Mamo, Aline, primary, Chabot, Catherine, primary, Sirois, Isabelle, primary, Magliocco, Anthony, primary, Klimowicz, Alexander, primary, Tonin, Patricia N., primary, Buchanan, Marguerite, primary, Keilty, Dana, primary, Hassan, Saima, primary, Laperrière, David, primary, Mader, Sylvie, primary, Aleynikova, Olga, primary, and Basik, Mark, primary

Published
2023
Full Text
View/download PDF

45. Supplemental Figures S1-S8 from The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers

Author

Légaré, Stéphanie, primary, Cavallone, Luca, primary, Mamo, Aline, primary, Chabot, Catherine, primary, Sirois, Isabelle, primary, Magliocco, Anthony, primary, Klimowicz, Alexander, primary, Tonin, Patricia N., primary, Buchanan, Marguerite, primary, Keilty, Dana, primary, Hassan, Saima, primary, Laperrière, David, primary, Mader, Sylvie, primary, Aleynikova, Olga, primary, and Basik, Mark, primary

Published
2023
Full Text
View/download PDF

46. Supplemental Figure Legends from The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers

Author

Légaré, Stéphanie, primary, Cavallone, Luca, primary, Mamo, Aline, primary, Chabot, Catherine, primary, Sirois, Isabelle, primary, Magliocco, Anthony, primary, Klimowicz, Alexander, primary, Tonin, Patricia N., primary, Buchanan, Marguerite, primary, Keilty, Dana, primary, Hassan, Saima, primary, Laperrière, David, primary, Mader, Sylvie, primary, Aleynikova, Olga, primary, and Basik, Mark, primary

Published
2023
Full Text
View/download PDF

49. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Author

Bradley, Jeffrey D, Paulus, Rebecca, Komaki, Ritsuko, Masters, Gregory, Blumenschein, George, Schild, Steven, Bogart, Jeffrey, Hu, Chen, Forster, Kenneth, Magliocco, Anthony, Kavadi, Vivek, Garces, Yolanda I, Narayan, Samir, Iyengar, Puneeth, Robinson, Cliff, Wynn, Raymond B, Koprowski, Christopher, Meng, Joanne, Beitler, Jonathan, Gaur, Rakesh, Curran, Walter, Jr, and Choy, Hak

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results